General News

Fourth Quarter 2018 Results Conference Call

Conference Call Highlights:  Refreshed, strengthened management team Established strategic plan to become the preferred drug delivery partner for specific infusion therapies in select markets Net Revenue increased 12.4% to $17.4 million from $15.4 million Adjusted EBITDA* expanded to $2.7 million, up 73.9% from $1.6 million in 2017 This presentation contains forward-looking statements that involve risks … Continued

REPR November Investor Presentation – 11.13.18

Presentation Highlights: Net Sales increased 18.1% to $4.5 million Gross margin improved to 63.6% compared to 61.8% Net income grew to $386,553; 8.5% of net sales Don Pettigrew was appointed to President and Chief Commercial Officer on Spetmber 4th, 2018   This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited … Continued

Liolis Gateway September 2018 Presentation

Liolis Gateway Presentation Highlights: Global leader in mechanical infusion systems Flagship FREEDOM60® system enables self-administered home infusion Part of the solution to today’s healthcare challenges New senior leadership focused on growth & value creation This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of … Continued

Investor Updates

Liolis Gateway September 2018 Presentation

Liolis Gateway Presentation Highlights: Global leader in mechanical infusion systems Flagship FREEDOM60® system enables self-administered home infusion Part of the solution to today’s healthcare challenges New senior leadership focused on growth & value creation This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of … Continued

Appointment of Executive Officer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported)   September 4, 2018   REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter)   New … Continued

RMS to Present at the 8th Annual LD Micro Invitational Conference

Chester, NY / May 23, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Lead Independent Director Dan Goldberger will be presenting at the 8th annual LD Micro Invitational Conference taking place June 4-6, 2018 at the Luxe Sunset hotel in Bel-Air, California.   The Company’s presentation will take … Continued